Key facts
- Alignmt AI’s last known valuation is $34.0M (Jul 2025).
- It has raised $6.5M; the latest was Accelerator/Incubator ($30K) in Nov 2025.
- Notable investors include Alumni Ventures, AIX Ventures, Sancus Ventures, Healthworx Accelerator, Dent Capital — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Alignmt AI
- ·The full record, as it builds
Funding rounds
No funding rounds for Alignmt AI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Alignmt AI
Developer of a healthcare artificial intelligence and risk monitoring platform designed to automate the compliance process. The company's platform focuses on AI system certification and validity, risk mitigation assessment, communicating regulatory compliance with external stakeholders, and capturing user feedback, enabling healthcare enterprises to innovate with confidence by using a platform that prioritizes compliance by design.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2023
- Employees
- 7
- Website
- alignmt.ai/
- Ownership
- Privately Held (backing)
Alignmt AI doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Alignmt AI shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Alignmt AI in its N-PORT filings yet. We sweep new filings monthly.